Oragenics Inc SEC filings OGEN
Oragenics Inc has 1,003 filings in SEC EDGAR's recent list, going back to Jun 20, 2007. Its latest annual report, Form 10-K, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 16, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 16, 2026 | Sep 16, 2026 |
| 8-K |
Current report
Listing notice, Other events
|
Aug 28, 2026 | Aug 26, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 7, 2026 | Jul 1, 2026 |
| 3 | Initial insider ownership | Jul 7, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Material agreement, Officer or director change, Shareholder vote results
|
Jul 6, 2026 | Jun 29, 2026 |
| DEFA14A | Additional proxy material | May 20, 2026 | — |
| DEF 14A | Proxy statement | May 20, 2026 | May 20, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 19, 2026 | May 18, 2026 |
| PRE 14A | Preliminary proxy statement | May 8, 2026 | May 8, 2026 |
| 10-Q | Quarterly report | May 8, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Other events
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Other events
|
Apr 13, 2026 | Apr 13, 2026 |
| 8-K | Current report | Mar 31, 2026 | Mar 27, 2026 |
| EFFECT | Filing | Mar 20, 2026 | — |
| CORRESP | Letter to the SEC | Mar 19, 2026 | — |
| S-3/A | Filing | Mar 19, 2026 | — |
| 10-K | Annual report | Mar 16, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Other events
|
Mar 11, 2026 | Mar 10, 2026 |
| UPLOAD | Letter from the SEC | Jan 27, 2026 | — |
| S-3 | Shelf registration | Jan 22, 2026 | — |
| 8-K |
Current report
Material agreement
|
Jan 22, 2026 | Jan 22, 2026 |
| 4/A | Primary document | Jan 22, 2026 | Dec 11, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 21, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 20, 2026 | Jan 20, 2026 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 15, 2025 | Dec 11, 2025 |
| 144 | Notice of proposed sale | Dec 12, 2025 | — |
| 8-K |
Current report
Other events
|
Nov 12, 2025 | Nov 12, 2025 |
| 10-Q | Quarterly report | Nov 7, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Material agreement, Listing notice, Regulation FD disclosure
|
Oct 21, 2025 | Oct 16, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 2, 2025 | Sep 1, 2025 |
| 3 | Initial insider ownership | Sep 2, 2025 | Sep 1, 2025 |
| S-8 | Employee stock plan registration | Aug 26, 2025 | — |
| 8-K |
Current report
Other events
|
Aug 11, 2025 | Aug 11, 2025 |
| 10-Q | Quarterly report | Aug 8, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jul 2, 2025 | Jun 30, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 2, 2025 | — |
| 424B5 | Prospectus supplement | Jul 2, 2025 | — |
| EFFECT | Filing | Jun 30, 2025 | — |
| S-1/A | Amended registration statement | Jun 30, 2025 | — |
| CORRESP | Letter to the SEC | Jun 26, 2025 | — |
| CORRESP | Letter to the SEC | Jun 26, 2025 | — |
| CORRESP | Letter to the SEC | Jun 23, 2025 | — |
| S-1 | Registration statement | Jun 23, 2025 | — |
| 4 | Insider transaction | Jun 18, 2025 | Jun 17, 2025 |
| UPLOAD | Letter from the SEC | Jun 17, 2025 | — |
| 4 | Insider transaction | Jun 16, 2025 | Jun 13, 2025 |
| 3 | Initial insider ownership | Jun 16, 2025 | Dec 28, 2023 |
| 144 | Notice of proposed sale | Jun 13, 2025 | — |
| DRS | Filing | Jun 3, 2025 | — |
| DRSLTR | Filing | Jun 2, 2025 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
May 28, 2025 | May 27, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 20, 2025 | May 20, 2025 |
| 10-Q | Quarterly report | May 9, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Material agreement, Officer or director change, Shareholder vote results
|
May 2, 2025 | May 2, 2025 |
| UPLOAD | Letter from the SEC | Apr 28, 2025 | — |
| DEFA14A | Additional proxy material | Apr 11, 2025 | — |
| CORRESP | Letter to the SEC | Apr 11, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 10, 2025 | — |
| 8-K |
Current report
Other events
|
Apr 9, 2025 | Apr 9, 2025 |
| DEF 14A | Proxy statement | Apr 1, 2025 | Apr 1, 2025 |
| 8-K |
Current report
Other events
|
Mar 27, 2025 | Mar 27, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 19, 2025 | Mar 19, 2025 |
| 10-K | Annual report | Mar 14, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Other events
|
Mar 6, 2025 | Mar 6, 2025 |
| 8-K | Current report | Feb 18, 2025 | Feb 17, 2025 |
| 8-K |
Current report
Other events
|
Feb 5, 2025 | Feb 5, 2025 |
| RW | Filing | Feb 4, 2025 | — |
| 8-K |
Current report
Other events
|
Jan 21, 2025 | Jan 21, 2025 |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Jan 17, 2025 | Jan 15, 2025 |
| EFFECT | Filing | Jan 16, 2025 | — |
| CORRESP | Letter to the SEC | Jan 14, 2025 | — |
| S-1/A | Amended registration statement | Jan 8, 2025 | — |
| S-1/A | Amended registration statement | Dec 31, 2024 | — |
| CORRESP | Letter to the SEC | Dec 31, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 30, 2024 | — |
| S-1 | Registration statement | Dec 18, 2024 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Dec 16, 2024 | Dec 11, 2024 |
| S-8 | Employee stock plan registration | Dec 16, 2024 | — |
| 4 | Insider transaction | Dec 13, 2024 | Dec 11, 2024 |
| 4 | Insider transaction | Dec 9, 2024 | Dec 6, 2024 |
| 4 | Insider transaction | Dec 9, 2024 | Dec 6, 2024 |
| 144 | Notice of proposed sale | Dec 6, 2024 | — |
| 144 | Notice of proposed sale | Dec 6, 2024 | — |
| 8-K |
Current report
Agreement ended
|
Nov 29, 2024 | Nov 26, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| DEFA14A | Additional proxy material | Oct 31, 2024 | — |
| DEF 14A | Proxy statement | Oct 31, 2024 | Oct 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 18, 2024 | Oct 18, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 16, 2024 | Oct 15, 2024 |
| 8-K |
Current report
Material agreement
|
Oct 15, 2024 | Oct 11, 2024 |
| 424B5 | Prospectus supplement | Oct 11, 2024 | — |
| 8-K |
Current report
Other events
|
Oct 9, 2024 | Oct 9, 2024 |
| 4 | Insider transaction | Sep 20, 2024 | Sep 19, 2024 |
| 4 | Insider transaction | Sep 20, 2024 | Sep 19, 2024 |
| 4 | Insider transaction | Sep 20, 2024 | Sep 19, 2024 |
| 4 | Insider transaction | Sep 20, 2024 | Sep 19, 2024 |
| 4 | Insider transaction | Sep 20, 2024 | Sep 19, 2024 |
| 4 | Insider transaction | Sep 20, 2024 | Sep 19, 2024 |
| 4 | Insider transaction | Sep 20, 2024 | Sep 19, 2024 |
| 4 | Insider transaction | Sep 20, 2024 | Sep 19, 2024 |
| 4 | Insider transaction | Sep 20, 2024 | Sep 19, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 20, 2024 | Sep 19, 2024 |
| SC 13G | Ownership over 5% (passive) | Sep 11, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Sep 5, 2024 | Sep 4, 2024 |
| 424B5 | Prospectus supplement | Sep 5, 2024 | — |
| EFFECT | Filing | Sep 3, 2024 | — |
| CORRESP | Letter to the SEC | Sep 3, 2024 | — |
| CORRESP | Letter to the SEC | Sep 3, 2024 | — |
| S-1/A | Amended registration statement | Sep 3, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 23, 2024 | — |
| 8-K |
Current report
Other events
|
Aug 21, 2024 | Aug 21, 2024 |
| S-1 | Registration statement | Aug 16, 2024 | — |
| 8-K |
Current report
Listing notice, Other events
|
Aug 16, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Other events
|
Aug 14, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Other events
|
Aug 12, 2024 | Aug 12, 2024 |
| 10-Q | Quarterly report | Aug 9, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Other events
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Other events
|
Jul 22, 2024 | Jul 22, 2024 |
| 8-K |
Current report
Other events
|
Jul 10, 2024 | Jul 10, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 26, 2024 | Jun 25, 2024 |
| 424B5 | Prospectus supplement | Jun 25, 2024 | — |
| 424B5 | Prospectus supplement | Jun 25, 2024 | — |
| 8-K |
Current report
Listing notice
|
Jun 20, 2024 | Jun 18, 2024 |
| 8-K | Current report | May 23, 2024 | May 23, 2024 |
| 8-K |
Current report
Other events
|
May 22, 2024 | May 22, 2024 |
| 8-K |
Current report
Other events
|
May 17, 2024 | May 17, 2024 |
| 8-K |
Current report
Other events
|
May 16, 2024 | May 16, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Other events
|
May 7, 2024 | May 7, 2024 |
| 8-K |
Current report
Listing notice, Other events
|
Apr 22, 2024 | Apr 18, 2024 |
| 8-K | Current report | Apr 16, 2024 | Apr 15, 2024 |
| 10-K | Annual report | Mar 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Other events
|
Mar 18, 2024 | Mar 18, 2024 |
| SC 13G | Ownership over 5% (passive) | Mar 6, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Mar 1, 2024 | Feb 27, 2024 |
| 424B5 | Prospectus supplement | Feb 29, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 28, 2024 | Feb 27, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 28, 2024 | Feb 27, 2024 |
| FWP | Free writing prospectus | Feb 27, 2024 | — |
| 424B5 | Prospectus supplement | Feb 27, 2024 | — |
| SC 13D | Ownership over 5% (active) | Feb 12, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Feb 12, 2024 | Feb 12, 2024 |
| 8-K |
Current report
Other events
|
Feb 7, 2024 | Feb 7, 2024 |
| 8-K |
Current report
Other events
|
Feb 5, 2024 | Feb 5, 2024 |
| 8-K |
Current report
Agreement ended, Other events
|
Jan 23, 2024 | Jan 23, 2024 |
| 5 | Annual insider ownership | Jan 22, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Other events
|
Jan 16, 2024 | Jan 16, 2024 |
| FWP | Free writing prospectus | Jan 16, 2024 | — |
| 424B5 | Prospectus supplement | Jan 16, 2024 | — |
| S-8 | Employee stock plan registration | Jan 10, 2024 | — |
| 4 | Insider transaction | Jan 2, 2024 | Dec 28, 2023 |
| 3 | Initial insider ownership | Jan 2, 2024 | Dec 28, 2023 |
| 8-K |
Current report
Other events
|
Jan 2, 2024 | Jan 2, 2024 |
| 8-K |
Current report
Acquisition or sale of assets, Officer or director change
|
Dec 29, 2023 | Dec 28, 2023 |
| 8-K |
Current report
Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Dec 15, 2023 | Dec 14, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 8, 2023 | Dec 4, 2023 |
| 4 | Insider transaction | Dec 1, 2023 | Nov 30, 2023 |
| 144 | Notice of proposed sale | Nov 30, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 20, 2023 | Nov 20, 2023 |
| DEFA14A | Additional proxy material | Nov 16, 2023 | — |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Other events
|
Nov 2, 2023 | Nov 2, 2023 |
| DEFA14A | Additional proxy material | Nov 2, 2023 | — |
| DEFA14A | Additional proxy material | Oct 30, 2023 | — |
| DEF 14A | Proxy statement | Oct 30, 2023 | Oct 30, 2023 |
| PRE 14A | Preliminary proxy statement | Oct 10, 2023 | Oct 6, 2023 |
| 4 | Insider transaction | Oct 6, 2023 | Oct 4, 2023 |
| 4 | Insider transaction | Oct 6, 2023 | Oct 4, 2023 |
| 3 | Initial insider ownership | Oct 6, 2023 | Oct 4, 2023 |
| 3 | Initial insider ownership | Oct 6, 2023 | Oct 4, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 5, 2023 | Oct 4, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 5, 2023 | Oct 4, 2023 |
| 8-K |
Current report
Other events
|
Sep 29, 2023 | Sep 26, 2023 |
| 8-K |
Current report
Agreement ended
|
Sep 15, 2023 | Sep 13, 2023 |
| 8-K |
Current report
Auditor change
|
Aug 18, 2023 | Aug 18, 2023 |
| 10-Q | Quarterly report | Aug 11, 2023 | Jun 30, 2023 |
| 4 | Insider transaction | Aug 10, 2023 | Aug 8, 2023 |
| 4 | Insider transaction | Aug 10, 2023 | Aug 8, 2023 |
| 4 | Insider transaction | Aug 10, 2023 | Aug 8, 2023 |
| 4 | Insider transaction | Aug 10, 2023 | Aug 8, 2023 |
| 4 | Insider transaction | Aug 10, 2023 | Aug 8, 2023 |
| 4 | Insider transaction | Aug 10, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 10, 2023 | Aug 8, 2023 |
| D | Filing | Aug 8, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Aug 7, 2023 | Aug 7, 2023 |
| 8-K |
Current report
Other events
|
Jun 5, 2023 | Jun 5, 2023 |
| 10-Q | Quarterly report | May 12, 2023 | Mar 31, 2023 |
| 10-K | Annual report | Apr 17, 2023 | Dec 31, 2022 |
| 10-Q/A | Amended quarterly report | Apr 14, 2023 | Sep 30, 2022 |
| 10-Q/A | Amended quarterly report | Apr 14, 2023 | Jun 30, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OGEN (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Lakewood Ranch, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1174940
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.